
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/3-FPM: Difference between revisions
Jump to navigation
Jump to search
>Rhz m Text replacement - "([A-Za-z]+) ([a-z]+) min dose" to "$1 min $2 dose" |
>Rhz m Text replacement - "([A-Za-z]+) ([a-z]+) max dose" to "$1 max $2 dose" |
||
Line 84: | Line 84: | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=[[Insufflated threshold dose::5]] - 10 [[Insufflated dose units::mg]] | |InsufflatedROA_Threshold=[[Insufflated threshold dose::5]] - 10 [[Insufflated dose units::mg]] | ||
|InsufflatedROA_Light=[[Insufflated min light dose::10]] - [[Insufflated light | |InsufflatedROA_Light=[[Insufflated min light dose::10]] - [[Insufflated max light dose::20]] mg | ||
|InsufflatedROA_Common=[[Insufflated min common dose::20]] - [[Insufflated common | |InsufflatedROA_Common=[[Insufflated min common dose::20]] - [[Insufflated max common dose::35]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::35]] - [[Insufflated strong | |InsufflatedROA_Strong=[[Insufflated min strong dose::35]] - [[Insufflated max strong dose::50]] mg | ||
|InsufflatedROA_Heavy=50 mg + | |InsufflatedROA_Heavy=50 mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= |
Revision as of 02:19, 9 May 2016
SubstanceBox/3-FPM | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||
Common names | 3-FPM, PAL-593 | ||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 3-Fluorophenmetrazine | ||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 2-(3-fluorophenyl)-3-methylmorpholine | ||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||
|